ALPHA TRADE
VIETNAM’S LEADING PHARMACEUTICAL RAW MATERIAL SUPPLIER
Within Aikya, Alpha Trade plays a pivotal role in ensuring supply chain security and serves as a premier, trusted commercial partner for pharmaceutical raw materials. Driving our operations with the philosophy: “Quality First, Unwavering Prestige, Mutual Growth,” we provide comprehensive raw material solutions that comply with Good Storage Practice (GSP) and Good Distribution Practice (GDP) standards, generating a powerful impetus to elevate the value chain of Vietnam’s pharmaceutical industry.
NATIONWIDE
DISTRIBUTION NETWORK
Proud of our foundation as a robust Vietnamese enterprise, we currently operate a system of over 22 strategic distribution branches, forming a comprehensive medical supply chain across the country. This core competency is continuously fortified by our strategic development of over 400 highly qualified medical representatives and a diverse ecosystem featuring more than 700 registered products.
We are committed to remaining highly responsive and supporting our partners with a dedicated fleet of transport vehicles, ensuring fast and on-time delivery. Furthermore, leveraging our large-scale logistics capacity and a strategy of maintaining safe, multi-sourced regional inventory, Alpha Trade minimizes supply chain risks, preventing disruptions in the flow of goods even amidst market volatility.
DEEP UNDERSTANDING
OF LOCAL AND GLOBAL MARKETS
At Alpha Trade, we don’t just distribute products; we distribute value. With extensive knowledge of local markets, Alpha Trade promotes a customer-centric culture in our sales approach. We have experienced senior sales managers who oversee operations, optimize efficiency, and ensure a deep understanding of customer needs
MARKET ACCESS WITH
SUPERIOR PRODUCT REGISTRATION SYSTEM
At Aikya, we understand that product registration is a crucial factor in ensuring that new pharmaceu- tical products can quickly reach the market and meet urgent needs. We have invested heavily in building a product registration team of experienced experts who can expedite the registration process. This not only optimizes the product launch process but also strengthens our position as a reliable partner com- mitted to delivering high-quality medical solutions without unnecessary delays.
CREATING COMPETITIVE ADVANTAGES
THROUGH API TRADING
Securing high-quality Active Pharmaceutical Ingredients (APIs) at competitive costs is Alpha Trade’s core competency. Our outstanding advantages are built upon:
Value-Added Services & Market Data: We proactively support drug registration dossiers, independent sample testing, batch traceability, and consultation for equivalent alternatives. We provide real-time data streams on pricing and lead times, empowering businesses to forecast accurately and make faster decisions.
Premium International Standards: We rigorously screen our supplier network, ensuring they hold GMP/CEP/DMF/ISO certifications with transparent Certificates of Analysis (COA) and clear origins, allowing our partners to confidently sign long-term contracts.
Cost Optimization & Vision for Autonomy: We import directly from global manufacturing plants and accept orders for all types of raw materials. By consolidating large demand, we help partners negotiate better prices, optimize inventory and logistics, and significantly improve cash flow. Looking ahead to 2035, the commissioning of our API Manufacturing Plant in the Tra Vinh Pharmaceutical Industrial Park will mark a historic milestone, opening opportunities for deep collaboration starting from the base materials.
EXPLORING
INTERNATIONAL MARKETS
Driven by the aspiration to build Vietnamese pharmaceutical pride on the global stage, Alpha Trade has established a commercial presence in 6 strategic countries (Cambodia, Yemen, Afghanistan, Azerbaijan, Myanmar, and Djibouti), targeting an export turnover of $10 million by 2028.
Alongside our international ambitions, this operational sector delivers positive macroeconomic impacts for Vietnam’s pharmaceutical industry:
Supply Stability & Quality Elevation: We reduce monopolistic dependence on a few raw material markets, helping domestic factories maintain production and mitigate drug shortages. We promote GMP and GDP compliance by filtering internationally standardized suppliers and clarifying multi-party responsibilities through transparent QMS/GDP systems, batch numbers, and COAs.
System Cost Reduction & Localization Promotion: Optimizing transportation, customs clearance, and testing helps lower costs, enabling domestic drugs to compete more effectively. We leverage pricing and demand data to encourage the domestic production of excipients and packaging in viable areas, aiming to reduce the trade deficit.
ESG & Business Ethics: We pioneer the implementation of anti-counterfeiting policies, apply rigorous EHS (Environment, Health, and Safety) assessment protocols for our suppliers, and practice responsible sourcing disclosure.
